Investment Summary

Cinven Invests In Taxwell

On February 5, 2021, private equity firm Cinven invested in software company Taxwell

Investment Highlights
  • This is Cinven’s 5th transaction in the Software sector.
  • This is Cinven’s 17th transaction in the United States.
  • This is Cinven’s 4th transaction in North Carolina.

Investment Summary
Date 2021-02-05
Target Taxwell
Sector Software
Investor(s) Cinven
Deal Type Growth Capital
Advisor(s) Deloitte (Financial)
Chambliss, Bahner & Stophel (Legal)

Target

Taxwell

Franklin, North Carolina, United States
Taxwell is a provider of tax preparation software to professionals and individuals. The Company provides the tools and resources that tax professionals need to build their businesses and properly file federal, state, and local taxes across the country. Drake Software was founded in 1977 and is based in Franklin, North Carolina.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Cinven

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1977
PE ASSETS 39.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cinven is a private equity firm focused on buyout investments in growing, profitable businesses located throughout Europe and North America. Sectors of interest include business and financial services, healthcare, industrial, retail, leisure, consumer, technology, media, and telecommunications. Cinven looks to invest a minimum of €200 million in companies with minimum enterprise values of €400 million. Cinven does not invest in start-ups or development phase companies. Cinven was established in 1977 and is headquartered in London.

DEAL STATS #
Overall 168 of 184
Sector (Software) 5 of 7
Type (Growth Capital) 6 of 6
State (North Carolina) 4 of 5
Country (United States) 17 of 20
Year (2021) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-10 BioClinica

Princeton, New Jersey, United States

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-08 Arxada

Basel, Switzerland

Arxada is a provider of specialty chemicals for microbial control solutions, used to eliminate or control harmful and unwanted micro-organisms. Arxada’s products are critical ingredients in disinfectants, preservatives, sanitisers, personal care products, as well as coatings and other industrial uses. Arxada was founded in 1897 and is based in Basel, Switzerland.

Buy Fr.4.2B
Mergr

Product

Company

Legal